SEBI-Approved 5 IPOs From Diverse Segments

By Kotak News Desk
|
17 Feb 2026 at 2:36 PM IST
|
Market News
|
4m

Summary

SEBI has greenlit five diverse companies, including Duroflex and Virupaksha Organics, to launch their IPOs. Spanning the consumer, pharmaceutical, and industrial sectors, these approvals signal a busy primary market. Read ahead to know more.

The Securities and Exchange Board of India (SEBI) has greenlit IPOs of five companies. These companies include Duroflex, Virupaksha Organics, Hexagon Nutrition, Premier Industrial Corporation, and Om Power Transmission.

The companies received the regulator’s “observations” between 10 February and 13 February, which effectively clears the way for them to proceed with their Initial Public Offerings (IPOs).

The five diverse companies represent a healthy mix of the Indian economy. These businesses cover everything from the mattresses we sleep on to the micronutrients in our food and the power lines that light our homes.

These filings were mostly submitted in late 2025. Now, they have cleared the regulatory hurdles and have received a one-year window to list on exchanges.

The important question for the investors is: are you prepared to navigate this wave of upcoming public issues as the market appetite for mid-cap stories remains robust?

IPO Details Of The Five Companies

Here are the brief details about the five companies that have received the SEBI nod:

Duroflex

Duroflex is a household name in the "sleep solutions" space. The company is looking to utilise its IPO proceeds to considerably expand its market presence through its Company-Owned Company-Operated (COCO) stores. COCO stores are different from traditional dealerships and are flagship outlets managed directly by the brand.

Duroflex plans to set up new COCO stores for direct retail and high-margin "sleep-tech" products. Here is a table summarising the issue.


Issue Type	Fresh Issue + Offer for Sale (OFS)
Fresh Issue Size	₹183.6 Cr.
Offer for Sale	2.25 Cr. Equity Shares
Primary Use of Funds	120 new COCO stores, Marketing, debt repayment
Main Business	Mattresses, Pillows, and Sleep-tech

Virupaksha Organics

Virupaksha Organics, a Telangana-based pharmaceutical company, has opted for an entirely fresh issue. The IPO funds are earmarked for capacity expansion and debt repayment. By reducing debt, the company might be able to improve the "bottom line." Also, since it is a research-driven pharma firm, having a clean balance sheet can help it to more aggressively invest in R&D and new manufacturing lines.


Issue Type	100% Fresh Issue
Total Value	₹740 Cr.
Primary Use of Funds	Capacity expansion and debt repayment
Main Business	Research driven pharma and application programming interfaces (APIs)

Hexagon Nutrition

Hexagon Nutrition had previously received approval for its IPO years ago (in 2022), but it chose not to list. Now, they are back with a pure OFS. This company manufactures micronutrient premixes. Since it is a pure OFS, the founding family is passing the ownership to public shareholders.


Issue Type	100% OFS
Total Shares	3.08 Cr. Equity Shares
Primary Use of Funds	Providing promoters exit to the Kelkar Family and existing investors
Main Business	Micronutrient premixes and clinical nutrition

Premier Industrial Corporation

Premier Industrial operates in the welding segment, focusing on the production and supply of welding consumables and related raw materials. Welding consumables is a sector that thrives when infrastructure and manufacturing are booming. The total issue size of the IPO is 2.79 Cr shares. The fresh issue IPO funds are planned to be used for building new facilities in Raigad.


Issue Type	Fresh Issue + Offer for Sale (OFS)
Fresh Issue Portion	2.25 Cr. Equity Shares
Offer For Sale	54 lakh shares
Primary Use of Funds	New manufacturing facility at Raigad and Wada unit expansion
Main Business	Welding consumables (powders and wires)

Om Power Transmission

Om Power Transmission operates in the EPC (Engineering, Procurement, and Construction) segment. The total issue size of the IPO is 1 Cr. equity shares.


Issue Type	Fresh Issue + Offer for Sale (OFS)
Fresh Issue Portion	90 lakh shares
Offer For Sale	10 lakh shares
Primary Use of Funds	Purchase of equipment, repayment of debt and promoter liquidation
Core Business	Power Transmission engineering, procurement and construction (EPC)

These companies form a core part of India’s industrial ecosystem. Their decision to list suggests that the momentum under the Make in India programme is beginning to translate into visible progress.

Investor Takeaways

The approval of these five companies could indicate that SEBI is clearing the path for a very diverse listing season. Whether you are a fan of "defensive" sectors like pharma and nutrition or "cyclical" sectors like infrastructure and welding, the menu is becoming quite diversified.

As the companies proceed towards forming IPO announcement details, it would be interesting to know their listing timelines and view their post-listing performance.

Source:

Fortune India

Moneycontrol

India IPO

Kotak Neo News Desk is a team of enthusiastic market observers backed by Kotak’s 30+ years of legacy, working round the clock to bring the latest news about equities, IPOs, corporate developments, commodities, and economic trends from the financial world.

This article is for informational purposes only and does not constitute financial advice. It is not produced by the desk of the Kotak Securities Research Team, nor is it a report published by the Kotak Securities Research Team. The information presented is compiled from several secondary sources available on the internet and may change over time. Investors should conduct their own research and consult with financial professionals before making any investment decisions. Read the full disclaimer https://www.kotaksecurities.com/disclaimer/research/.

Investments in securities market are subject to market risks, read all the related documents carefully before investing. Brokerage will not exceed SEBI prescribed limit. The securities are quoted as an example and not as a recommendation. SEBI Registration No-INZ000200137 Member Id NSE-08081; BSE-673; MSE-1024, MCX-56285, NCDEX-1262

About the Author